Toujeo comes as two pens: Toujeo SoloStar and Toujeo Max SoloStar. Both forms of the drug contain the same active ingredient, insulin glargine. The following chart compares these pens: ...

Toujeo is an injectable insulin medication for the treatment of diabetes (type 1 or type 2) in people who are 6 years old and older. It is a long-acting form of insulin, which allows it to last ...

Toujeo is a prescription drug used to help manage blood sugar in type 1 and type 2 diabetes. Learn about the drug’s dosages, forms, strengths, and more.

Toujeo is a prescription drug used in people with diabetes. Learn about the common, mild, and serious side effects it can cause and how to manage them.

Toujeo, which is used to treat type 1 and type 2 diabetes, can cause side effects. Learn about its more common, mild, and serious side effects.

The EDITION JUNIOR study1 compared Toujeo to Gla-100 in 463 children and adolescents (aged 6 to 17 years) treated for type 1 diabetes for at least one year and with HbA1c between 7.5% and 11.0% at ...

The FDA has expanded the indication for Toujeo (insulin glargine; Sanofi) 300 Units/mL to include treatment of pediatric patients aged ≥6 years with diabetes mellitus.

Toujeo was approved for use in the United States on Feb. 25 and was recommended for approval by European regulators two days later. Sanofi has previously said it planned the launch for the ...

Toujeo is supplied as a solution containing 300U/mL (U-300) in 1.5mL SoloStar disposable prefilled pens in 3- and 5-count packages. For more information call (800) 633-1610 or visit Toujeo.com.

Toujeo lasts longer than Lantus, however. 1 It also provides the body a steadier stream of insulin1 and is associated with a significantly lower risk of nocturnal hypoglycemia. 1.

Sanofi's U-300, or ultralong-acting insulin glargine, Toujeo has been given a positive opinion by the CHMP of the European Medicines Agency. The product is designed to improve on Lantus.

BRIDGEWATER, N.J., March 27, 2018 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) approved Sanofi's Toujeo® (insulin glargine 300 Units/mL) Max SoloStar®, the highest capacity long ...